| Heather Fowler-pruchnicki, LPC | |
|
611 W Market St, Akron, OH 44303-1411 | |
| (330) 996-4600 | |
| (330) 564-9296 |
| Full Name | Heather Fowler-pruchnicki |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 611 W Market St, Akron, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013689884 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | C.2103614 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Heather Fowler-pruchnicki, LPC 611 W Market St, Akron, OH 44303-1411 Ph: (330) 996-4600 | Heather Fowler-pruchnicki, LPC 611 W Market St, Akron, OH 44303-1411 Ph: (330) 996-4600 |
News Archive
Invida Group Pte Ltd, the leading specialty biopharmaceutical company focused on the commercialization of healthcare products throughout Asia Pacific, today announced that it has entered into an agreement with Amdipharm for the licensing and commercialization of its proprietary products throughout Asia. Under this agreement, Invida will leverage its full suite of capabilities to bring Amdipharm's products to market, from regulatory approval and licensing, through packaging and supply chain optimization, to commercialization, sales, and marketing.
Carrying two copies of a common variant of a particular gene doubles your chances of developing diabetes and puts you in a similar risk category to being clinically obese, according to a collaborative study led by UCL (University College London) researchers.
In an alliance aimed at bringing a new, personalized immunotherapy approach to patients with a wide variety of cancers, the University of Pennsylvania and Novartis announced today an exclusive global research and licensing agreement to further study and commercialize novel cellular immunotherapies using chimeric antigen receptor (CAR) technologies.
Merck & Co., Inc., known outside the U.S. and Canada as MSD, today provided further detail on integration plans for the company's research and development, manufacturing and other business operations as part of a global restructuring program announced following the November 2009 merger of Merck and Schering-Plough.
Work has officially begun on the construction of a new sanofi pasteur manufacturing facility that will expand the ability of the United States to produce influenza vaccine for both routine influenza immunization and in case of a global influenza pandemic.
› Verified 4 days ago
Dr. James M Athans, PCC/S, LICDC, SAP Counselor Medicare: Not Enrolled in Medicare Practice Location: 212 East Exchange St, Greenleaf Family Center, Akron, OH 44304 Phone: 330-376-9494 Fax: 330-376-4525 | |
Amy Zeglen, PCC-S Counselor Medicare: Not Enrolled in Medicare Practice Location: 380 S Portage Path, Akron, OH 44320 Phone: 330-315-4918 | |
Shelli Fullum, Counselor Medicare: Not Enrolled in Medicare Practice Location: 611 W Market St, Akron, OH 44303 Phone: 330-996-4600 Fax: 330-643-0767 | |
Brianne Markley, Counselor Medicare: Not Enrolled in Medicare Practice Location: 340 S Broadway St, Akron, OH 44308 Phone: 330-253-3100 | |
Marshon Whitley, LCDCIII Counselor Medicare: Not Enrolled in Medicare Practice Location: 665 W Market St, Akron, OH 44303 Phone: 330-379-3467 Fax: 330-379-3465 | |
Patricia Dudley, MSED, LPCC-S, LICDC Counselor Medicare: Not Enrolled in Medicare Practice Location: 18 N Forge St, Akron, OH 44304 Phone: 330-762-0591 | |
Maribeth Lieberth, M.A. L.P.C. Counselor Medicare: Not Enrolled in Medicare Practice Location: 900 Mull Ave, Akron, OH 44313 Phone: 800-621-5207 |